missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Reactivos para análisis de proteínas
  4. Toxinas
  5. 16400556

MedChemExpress Epoxomicin

Código de producto. 16400556
Encompass_Preferred
Cambiar vista
Click to view available options
20 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Código de producto.
16400556 20 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Este artículo no se puede devolver. Vea la política de devoluciones
Código de producto. 16400556 Proveedor MedChemExpress N.º de proveedor HY13821

Please to purchase this item. Need a web account? Register with us today!

Este artículo no se puede devolver. Vea la política de devoluciones

Descripción

MedChemExpress Epoxomicin (BU-4061T) is an epoxyketone-containing natural product and a potent, selective and irreversible proteasome inhibitor. Epoxomicin covalently binds to the LMP7, X, MECL1, and Z catalytic subunits of the proteasome and potently inhibits primarily the chymotrypsin-like activity. Epoxomicin can cross the blood-brain barrier. Epoxomicin has strongly antitumor and anti-inflammatory activity.

Especificaciones

Contenido y almacenamiento Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Peso molecular 554.72 g/mol
Condiciones de envío Room temperature
Para utilizar con (aplicación) Cancer-Kinase/protease
CAS 134381-21-8
Tipo de producto Natural Products
Pureza 95.0%
Solubilidad DMSO : 100 mg/mL (180.27 mM∣Need ultrasonic)
Sinónimo BU-4061T
Objetivo Proteasome∣Apoptosis
Cantidad 20 mg
Mostrar más Mostrar menos
Título del producto
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.